Skip to main content
Log in

Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The pharmacokinetics of misonidazole, a hypoxic-cell radiosensitizer, were determinated after intraperitoneal administration to standardized Balb/c mice.

The experimental data was fitted, using non linear analysis, to plasma-concentration curves described by tri-exponential equations derived from a two-compartment model.

The pharmacokinetic constants (absorption and elimination coefficients) were determinated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams G.E. and Flowler J.F. (1976) In: Modification of radiosensitivity of biological systems. I.A.E.A. (Vienne) pp 103–117.

  2. Adams G.E., Fowler J.F. and Wardman P. (1978) Hypoxic cell sensitizers in radiobiology and radio-therapy. Br. J. Cancer (suppl. 3). 37, 1–321.

    Google Scholar 

  3. Fowler J.F. and Denekamp J. (1976) Radiosensitizers of hypoxic cells in solid tumours. Cancer Treat. Rev., 3, 227–256.

    Article  CAS  PubMed  Google Scholar 

  4. Fowler J.F. (1980) Hypoxic cell radiosensitizers: present status and future promise.In: Radiation biology in cancer research. Meyn R.E. and Withers H.R. (ed.). Raven Press, New-York, pp 533–546.

    Google Scholar 

  5. Dische S., Saunders M.J., Lee M.E., Adams G.E. and Flockhart I.R. (1977) Clinical testing of the radiosensitizer Ro-07-0582. Experience with multiple dose. Br. J. Cancer, 35, 567–579.

    CAS  PubMed  Google Scholar 

  6. Urtasun R.C., Chapman J.D., Feldstein M.L., Band R.P., Rabin H.R., Wilson A.F., Marynowsky B., Starreveld E. and Shnitka T. (1978) Peripheral neuropathy related to misonidazole: incidence and pathology. Br. J. Cancer, 37, Suppl. III, 271–276.

    Google Scholar 

  7. Veng Pedersen P. and Miller R. (1980) Pharmacokinetics and bioavailability of Cimetidine in Humans. J. Pharm. Sci., 69 (4), 394–398.

    Article  Google Scholar 

  8. Chapman J.D., Reuvers A.R., Borsa J., Henderson J.H. and Migliore R.D. (1974) Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells. Cancer Chemother. Rep. 58, 559–570.

    CAS  PubMed  Google Scholar 

  9. Brown J.M., Yu N.Y. and Workman P. (1979) Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours. Br. J. Cancer, 39, 310–320.

    CAS  PubMed  Google Scholar 

  10. Wagner J.G. (1975) Fundamentals of clinical pharmacokinetics. Hamilton Press, Hamilton, III., pp. 112, 231–246.

    Google Scholar 

  11. Conroy P.J., Von Burg R., Passalacqua W. and Sutherland R.M. (1980). The effect of misonidazole on some physiologic parameters in mice. J. Pharm. Exp. Ther., 212, (1), 47–52.

    CAS  Google Scholar 

  12. Flockhart J.R., Large P., Troup D., Malcolm S.L. and Marten T.R. (1978). Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole. Xenobiotica, 8, (2), 97–105.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malmary-Nebot, MF., Labat, C., Terrissol, M. et al. Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse. European Journal of Drug Metabolism and Pharmacokinetics 7, 17–20 (1982). https://doi.org/10.1007/BF03189538

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189538

Key words

Navigation